{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:22:02Z","timestamp":1789132922401,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX10201201-001"],"award-info":[{"award-number":["2017ZX10201201-001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Key Project on \u201cMajor Infectious Diseases such as HIV\/AIDS, Viral Hepatitis Prevention and Treatment\u201d","award":["2017ZX10201201-002"],"award-info":[{"award-number":["2017ZX10201201-002"]}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals Ascent Plan","doi-asserted-by":"crossref","award":["DFL20151601"],"award-info":[{"award-number":["DFL20151601"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Appropriate passive-active immunoprophylaxis effectively reduces mother-to-child transmission (MTCT) of hepatitis B virus (HBV), but the immunoprophylaxis failure was still more than 5% under the current strategy. The study objective was to investigate the effects of high dose of HB vaccine on MTCT and immune response for infants born to hepatitis B surface antigen (HBsAg)-positive mothers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a prospective, multicenter, large-sample cohort study in four sites of China, and 955 pairs of HBsAg-positive mothers and their infants were enrolled in our investigation. The infants were given 10\u2009\u03bcg or 20\u2009\u03bcg HB vaccine (at age 0, 1, and 6\u2009months) plus HB immunoglobulin (at age 0 and 1\u2009month). Serum HBsAg, antibody to HBsAg (anti-HBs), and\/or HBV DNA levels in the infants were determined at age 12\u2009months. The safety of 20\u2009\u03bcg HB vaccine was evaluated by adverse events and observing the growth indexes of infants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirteen of 955 infants were HBsAg-positive at 12\u2009months. Stratification analysis showed that immunoprophylaxis failure rates in the 20\u2009\u03bcg group were not significantly different from the 10\u2009\u03bcg group, whatever maternal HBV load was high or not. But the high dose of HB vaccine significantly reduced low-response rate (anti-HBs 10\u2013100\u2009IU\/L) (<jats:italic>P<\/jats:italic> = 0.002) and middle-response rate (anti-HBs 100\u20131000\u2009IU\/L) (<jats:italic>P<\/jats:italic> = 0.022) and improved high-response rate (anti-HBs \u2265 1000\u2009IU\/L) (<jats:italic>P<\/jats:italic> &lt;\u20090.0001) in infants born to mothers with HBV DNA &lt;\u20095 log<jats:sub>10<\/jats:sub> IU\/mL. For infants born to mothers with HBV DNA \u2265 5 log<jats:sub>10<\/jats:sub> IU\/mL, 20\u2009\u03bcg HB vaccine did not present these above response advantages. The 20\u2009\u03bcg HB vaccine showed good safety for infants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The 20\u2009\u03bcg HB vaccine did not further reduce immunoprophylaxis failure of infants from HBsAg-positive mothers, but increased the high-response and decreased low-response rates for infants born to mothers with HBV DNA &lt;\u20095 log<jats:sub>10<\/jats:sub> IU\/mL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\">ChiCTR-PRC-09000459<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-021-02025-1","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T01:02:18Z","timestamp":1626138138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaohui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaibin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin Q.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"2025_CR1","unstructured":"Hepatitis B. World Health Organization Fact Sheets. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b.\u00a0Accessed 1 May 2020."},{"issue":"3","key":"2025_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230\u20138. https:\/\/doi.org\/10.2471\/BLT.18.219469.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"2025_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/rmv.1801","volume":"24","author":"L Ma","year":"2014","unstructured":"Ma L, Alla NR, Li X, Mynbaev OA, Shi Z. Mother-to-child transmission of HBV: review of current clinical management and prevention strategies. Rev Med Virol. 2014;24(6):396\u2013406. https:\/\/doi.org\/10.1002\/rmv.1801.","journal-title":"Rev Med Virol"},{"issue":"6","key":"2025_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12072-017-9825-y","volume":"11","author":"JS Park","year":"2017","unstructured":"Park JS, Pan CQ. Viral factors for HBV mother-to-child transmission. Hepatol Int. 2017;11(6):476\u201380. https:\/\/doi.org\/10.1007\/s12072-017-9825-y.","journal-title":"Hepatol Int"},{"issue":"9","key":"2025_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/jvh.13123","volume":"26","author":"M Zhao","year":"2019","unstructured":"Zhao M, Zou H, Chen Y, Zheng S, Duan Z. Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus. J Viral Hepat. 2019;26(9):1059\u201365. https:\/\/doi.org\/10.1111\/jvh.13123.","journal-title":"J Viral Hepat"},{"issue":"21","key":"2025_CR6","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3748\/wjg.v10.i21.3215","volume":"10","author":"XM Li","year":"2004","unstructured":"Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol. 2004;10(21):3215\u20137. https:\/\/doi.org\/10.3748\/wjg.v10.i21.3215.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2025_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijgo.2006.11.011","volume":"96","author":"XM Xiao","year":"2007","unstructured":"Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet. 2007;96(3):167\u201370. https:\/\/doi.org\/10.1016\/j.ijgo.2006.11.011.","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"2025_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/jp.2014.167","volume":"34","author":"JC Dunkelberg","year":"2014","unstructured":"Dunkelberg JC, Berkley EM, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol. 2014;34(12):882\u201391. https:\/\/doi.org\/10.1038\/jp.2014.167.","journal-title":"J Perinatol"},{"issue":"23","key":"2025_CR9","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/S0264-410X(03)00232-9","volume":"21","author":"N ul-Haq","year":"2003","unstructured":"ul-Haq N, Hasnain SS, Umar M, Abbas Z, Valenzuela-Silva C, Lopez-Saura P. Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine. 2003;21(23):3179\u201385.","journal-title":"Vaccine"},{"issue":"2","key":"2025_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0264-410X(95)00148-T","volume":"14","author":"M Chiaramonte","year":"1996","unstructured":"Chiaramonte M, Majori S, Ngatchu T, Moschen ME, Baldo V, Renzulli G, et al. Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity. Vaccine. 1996;14(2):135\u20137. https:\/\/doi.org\/10.1016\/0264-410X(95)00148-T.","journal-title":"Vaccine"},{"issue":"1","key":"2025_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/1054-139X(94)00105-N","volume":"16","author":"GM Schiff","year":"1995","unstructured":"Schiff GM, Sherwood JR, Zeldis JB, Krause DS. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J Adolesc Health. 1995;16(1):12\u20137. https:\/\/doi.org\/10.1016\/1054-139X(94)00105-N.","journal-title":"J Adolesc Health"},{"key":"2025_CR12","unstructured":"Chinese Society of Infectios Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). Zhonghua Gan Zang Bing Za Zhi. 2019;27(12):938-61."},{"issue":"10","key":"2025_CR13","doi-asserted-by":"publisher","first-page":"e26748","DOI":"10.1371\/journal.pone.0026748","volume":"6","author":"H Zou","year":"2011","unstructured":"Zou H, Chen Y, Duan Z, Zhang H. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. Plos One. 2011;6(10):e26748. https:\/\/doi.org\/10.1371\/journal.pone.0026748.","journal-title":"Plos One"},{"issue":"1","key":"2025_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12879-018-3166-x","volume":"18","author":"MZ Cao","year":"2018","unstructured":"Cao MZ, Wu YH, Wen SM, Pan YC, Wang C, Kong F, et al. Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)\/HBeAg(-) mothers. BMC Infect Dis. 2018;18(1):274. https:\/\/doi.org\/10.1186\/s12879-018-3166-x.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"2025_CR15","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.cgh.2013.04.026","volume":"11","author":"CQ Pan","year":"2013","unstructured":"Pan CQ, Zou HB, Chen Y, Zhang X, Zhang H, Li J, et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Clin Gastroenterol Hepatol. 2013;11(10):1349\u201355. https:\/\/doi.org\/10.1016\/j.cgh.2013.04.026.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2025_CR16","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","volume":"19","author":"H Zou","year":"2012","unstructured":"Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19(2):e18\u201325. https:\/\/doi.org\/10.1111\/j.1365-2893.2011.01492.x.","journal-title":"J Viral Hepat"},{"key":"2025_CR17","unstructured":"Capital Institute of Pediatrics,The Coordinating Study Group of Nine Cities on the Physical Growth and Development of Children. A national survey on physical growth and development of children under seven years of age in nine cities of China in 2015. Zhonghua Er Ke Za Zhi. 2018;56(3):192-9."},{"issue":"4","key":"2025_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","volume":"142","author":"HL Chen","year":"2012","unstructured":"Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142(4):773\u201381 e772. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.035.","journal-title":"Gastroenterology"},{"issue":"10","key":"2025_CR19","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/jmv.23667","volume":"85","author":"YZ Yin","year":"2013","unstructured":"Yin YZ, Zhang J, Wu LL, Zhou J, Zhang PZ, Zhou SS. Development of strategies for screening, predicting, and diagnosing intrauterine HBV infection in infants born to HBsAg positive mothers. J Med Virol. 2013;85(10):1705\u201311. https:\/\/doi.org\/10.1002\/jmv.23667.","journal-title":"J Med Virol"},{"issue":"2","key":"2025_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hep4.1460","volume":"4","author":"SS Joshi","year":"2020","unstructured":"Joshi SS, Coffin CS. Hepatitis B and pregnancy: virologic and immunologic characteristics. Hepatol Commun. 2020;4(2):157\u201371. https:\/\/doi.org\/10.1002\/hep4.1460.","journal-title":"Hepatol Commun"},{"issue":"7","key":"2025_CR21","first-page":"392","volume":"34","author":"Y Yan","year":"1999","unstructured":"Yan Y, Xu D, Wang W. The role of placenta in hepatitis B virus intrauterine transmission. Zhonghua Fu Chan Ke Za Zhi. 1999;34(7):392\u20135.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"2","key":"2025_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.27034","volume":"60","author":"H Zhang","year":"2014","unstructured":"Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60(2):468\u201376. https:\/\/doi.org\/10.1002\/hep.27034.","journal-title":"Hepatology"},{"issue":"24","key":"2025_CR23","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1508660.","journal-title":"N Engl J Med"},{"issue":"9","key":"2025_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/MCG.0000000000000908","volume":"51","author":"J Li","year":"2017","unstructured":"Li J, Chang MS, Tran TT, Nguyen MH. Management of chronic hepatitis B in pregnancy. J Clin Gastroenterol. 2017;51(9):789\u201395. https:\/\/doi.org\/10.1097\/MCG.0000000000000908.","journal-title":"J Clin Gastroenterol"},{"key":"2025_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.meegid.2018.06.006","volume":"63","author":"M Cao","year":"2018","unstructured":"Cao M, Wu Y, Wen S, Pan Y, Wang C, Zhang X, et al. 20mug hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers. Infect Genet Evol. 2018;63:243\u20138. https:\/\/doi.org\/10.1016\/j.meegid.2018.06.006.","journal-title":"Infect Genet Evol"},{"issue":"10","key":"2025_CR26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0264-410X(97)00005-4","volume":"15","author":"Y Lazizi","year":"1997","unstructured":"Lazizi Y, Badur S, Perk Y, Ilter O, Pillot J. Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine. 1997;15(10):1095\u2013100. https:\/\/doi.org\/10.1016\/S0264-410X(97)00005-4.","journal-title":"Vaccine"},{"issue":"3","key":"2025_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/infdis\/169.3.704","volume":"169","author":"S Badur","year":"1994","unstructured":"Badur S, Lazizi Y, Ugurlu M, Perk Y, Ilter O, Aydinli K, et al. Transplacental passage of hepatitis B virus DNA from hepatitis B e antigen-negative mothers and delayed immune response in newborns. J Infect Dis. 1994;169(3):704\u20136. https:\/\/doi.org\/10.1093\/infdis\/169.3.704.","journal-title":"J Infect Dis"},{"issue":"12","key":"2025_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/jvh.12103","volume":"20","author":"W Zhang","year":"2013","unstructured":"Zhang W, Guo Z, Zhang L, Liu Z, Li J, Ji Z, et al. Maternal immunization promotes the immune response of neonates towards hepatitis B vaccine. J Viral Hepat. 2013;20(12):875\u201381. https:\/\/doi.org\/10.1111\/jvh.12103.","journal-title":"J Viral Hepat"},{"issue":"11","key":"2025_CR29","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.2460\/ajvr.2005.66.1854","volume":"66","author":"AJ Reber","year":"2005","unstructured":"Reber AJ, Hippen AR, Hurley DJ. Effects of the ingestion of whole colostrum or cell-free colostrum on the capacity of leukocytes in newborn calves to stimulate or respond in one-way mixed leukocyte cultures. Am J Vet Res. 2005;66(11):1854\u201360. https:\/\/doi.org\/10.2460\/ajvr.2005.66.1854.","journal-title":"Am J Vet Res"},{"issue":"46","key":"2025_CR30","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1016\/j.vaccine.2014.08.078","volume":"32","author":"L Zhang","year":"2014","unstructured":"Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, et al. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Vaccine. 2014;32(46):6091\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.078.","journal-title":"Vaccine"},{"issue":"8","key":"2025_CR31","doi-asserted-by":"publisher","first-page":"e70768","DOI":"10.1371\/journal.pone.0070768","volume":"8","author":"H Su","year":"2013","unstructured":"Su H, Zhang Y, Xu D, Wang B, Zhang L, Li D, et al. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. Plos One. 2013;8(8):e70768. https:\/\/doi.org\/10.1371\/journal.pone.0070768.","journal-title":"Plos One"},{"issue":"3","key":"2025_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s15010-015-0733-6","volume":"43","author":"H Foaud","year":"2015","unstructured":"Foaud H, Maklad S, Mahmoud F, El-Karaksy H. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis. Infection. 2015;43(3):307\u201314. https:\/\/doi.org\/10.1007\/s15010-015-0733-6.","journal-title":"Infection"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02025-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02025-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02025-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T01:02:29Z","timestamp":1626138149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02025-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02025-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval for this study was obtained by the Ethics Committee of Beijing Youan Hospital, Capital Medical University (NO 200907). Written consents were obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}